D
Blueprint Medicines Corporation BPMC
$87.08 -$2.93-3.26%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -49.96M -56.27M -50.00M 89.14M -110.92M
Total Depreciation and Amortization 4.00M 3.86M 3.62M 4.81M 1.53M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 26.73M 23.31M 25.11M -152.26M 20.05M
Change in Net Operating Assets -10.14M 15.46M -26.81M -43.20M 10.40M
Cash from Operations -29.36M -13.64M -48.07M -101.51M -78.93M
Capital Expenditure -932.00K -25.00K -2.57M -1.10M -4.67M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 34.64M 29.98M -185.72M 78.24M 83.44M
Cash from Investing 33.71M 29.95M -188.29M 77.13M 78.77M
Total Debt Issued 0.00 0.00 146.97M -- -35.00K
Total Debt Repaid 0.00 0.00 -172.00K -369.00K -44.00K
Issuance of Common Stock 9.76M 18.38M 31.21M 67.33M 15.61M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 9.76M 18.38M 178.01M 66.96M 15.53M
Foreign Exchange rate Adjustments -1.32M 591.00K -31.00K -145.00K 487.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 12.78M 35.28M -58.38M 42.44M 15.86M
Weiss Ratings